Pharmacists are the medication experts on America’s health care team. The APhA Media Advisors and staff pharmacists can help the media make sense of pharmacist clinical services, over-the-counter products, prescription medications, vitamin and herbal supplements, as well as many other topics. These pharmacists are ready to help develop stories about medication use and how the pharmacist helps improve patient health and reduce health care costs.
Contact Chad Clinton in Communications at firstname.lastname@example.org or at 202-429-7558.
March 29, 2019
APhA2019: Moving Pharmacy Forward
The American Pharmacists Association (APhA) Annual Meeting & Exposition, APhA2019, held March 22–25, hosted almost 6,000 pharmacists and student pharmacists in Seattle. This year’s theme, Moving Pharmacy Forward, highlighted the pharmacist’s role in addressing public health concerns and promoted personal and professional well-being while continuing to prioritize patient care services.
March 11, 2019
APhA Partners with iForumRx.org on New Line of Ambulatory Care Recertification Tools
The American Pharmacists Association (APhA) announced a partnership with iForumRx.org, an interactive web-based community for ambulatory care pharmacy specialists, to produce a new line of recertification tools centered around podcasts, panel discussions, and polls.
April 9, 2019
What’s the right treatment plan for pharmacist workforce supply…
Imbalances between workforce supply and demand are notoriously difficult to resolve. Market corrections can take decades to work themselves out, and leaving the market to self-correct doesn’t help…0 comments
News View all news
Coalition of drug supply chain members welcomes pharmacist feedback on track-and-trace proposal
The November 2023 deadline for full implementation of the Drug Supply Chain Security Act (DSCSA) looms large, but many of the specifics are far from determined. DSCSA, also known as “track and trace,” mandates that all members of the U.S. supply chain—including pharmacies—use an interoperable electronic system that tracks a drug at the package level until it reaches the pharmacy. The policy is aimed at protecting consumers from counterfeit, stolen, contaminated, or otherwise harmful drugs, including through improved recall processes.
FDA expresses continued confidence in the safety and effectiveness of MMR vaccine
With an increasing number of measles outbreaks across the country and around the world, FDA is stressing its continued confidence in the measles, mumps, and rubella (MMR) vaccine. CDC has reported that outbreaks of mumps have also been reported in the United States this year.